Novabay Pharmaceuticals Inc

Research Novabay Pharmaceuticals Inc (NBY) on Bullrun: market cap USD 40.23M, dividend yield 259.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNBY
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 40.23M
• Dividend yield259.7%
• Financial periodQ4 2025
• Revenue-USD 521.00K
• Net income-USD 26.60M
• Free cash flow-USD 2.28M

Valuation Snapshot

latest market cap is USD 40.23M; dividend yield is 259.7%.

About Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.

Frequently asked questions

What is Novabay Pharmaceuticals Inc's market cap?

Novabay Pharmaceuticals Inc's market capitalization is USD 40.23M.

Does Novabay Pharmaceuticals Inc pay a dividend?

Novabay Pharmaceuticals Inc has a dividend yield of 259.7%.

What does Novabay Pharmaceuticals Inc do?

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.